Who owns HARPOON THERAPEUTICS INC?
- CUSIP Number: 41358p205
Tip: Access positions for across all investors
Analyze quarterly positions in Harpoon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Harpoon Therapeutics stock
Who bought or sold HARPOON THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cormorant Asset Management | 2.3M | $23M | 4245% | Dec 2023 |
|
| Commodore Capital | 1.5M | $17M | 100% | Dec 2023 |
|
| RA Capital Management | 1.5M | $17M | 100% | Dec 2023 |
|
| Franklin Resources | 1.5M | $17M | 1028% | Dec 2023 |
|
| Artal Group | 1.3M | $15M | 1204% | Dec 2023 |
|
| Vanguard Group | 880k | $10M | 676% | Dec 2023 |
|
| Soleus Capital Management | 821k | $9.3M | 100% | Dec 2023 |
|
| Blackstone Group | 815k | $9.3M | 100% | Dec 2023 |
|
| Citadel Advisors | 686k | $7.8M | 1292% | Dec 2023 |
|
| Lion Point Capital | 229k | $2.6M | 178% | Dec 2023 |
|
| Kennedy Capital Management | 52k | $593k | -2% | Dec 2023 |
|
| Goldman Sachs Group | 49k | $557k | 100% | Dec 2023 |
|
| Citigroup | 39k | $446k | 100% | Dec 2023 |
|
| Two Sigma Investments | 27k | $308k | 100% | Dec 2023 |
|
| Standard Life Aberdeen | 26k | $296k | 100% | Dec 2023 |
|
| Millennium Management | 26k | $290k | 139% | Dec 2023 |
|
| Charles Schwab Investment Management | 11k | $130k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 11k | $119k | 100% | Dec 2023 |
|
| Bank of America Corporation | 5.9k | $67k | 7824% | Dec 2023 |
|
| UBS Group | 2.6k | $30k | 4730% | Dec 2023 |
|
| Wells Fargo & Company | 181.00 | $2.1k | 99% | Dec 2023 |
|
| Jpmorgan Chase & Co | 134.00 | $1.5k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 107.00 | $1.2k | 0% | Dec 2023 |
|
| Barclays | 105.00 | $999.999000 | 100% | Dec 2023 |
|
| Hanson McClain Advisors | 40.00 | $455.000000 | 0% | Dec 2023 |
|
| Us Bancorp | 8.00 | $91.000000 | 0% | Dec 2023 |
|
Who sold out of Harpoon Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OrbiMed Advisors | Sep 2023 | 62k | $250k |
| Royal Bank of Canada | Sep 2023 | 80.00 | $0 |